Jung Jung Hwa, Hahm Jong Ryeal, Jung Jaehoon, Kim Soo Kyoung, Kim Sungsu, Kim Kyong Young, Kim Bo Ra, Kim Hong Jun, Jeong Yi Yeong, Kim Sun Joo
Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Korea. ; Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea.
Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Korea.
J Korean Med Sci. 2014 Aug;29(8):1170-3. doi: 10.3346/jkms.2014.29.8.1170. Epub 2014 Jul 30.
Methimazole (MMI)-induced acute pancreatitis is very rare but severe adverse reaction. A 51-yr-old male developed a high fever, chills, and abdominal pain, two weeks after commencement on MMI for the treatment of Graves' disease. There was no evidence of agranulocytosis, and fever subsided soon after stopping MMI treatment. However, 5 hr after taking an additional dose of MMI, abdominal pain and fever developed again. His symptoms, biochemical, and imaging studies were compatible with acute pancreatitis. After withdrawal of MMI, he showed clinical improvement. This is the first case of MMI-induced acute pancreatitis in Korea. Clinicians should be aware of the rare but possible MMI-induced pancreatitis in patients complaining of fever and abdominal pain.
甲巯咪唑(MMI)诱发的急性胰腺炎是一种非常罕见但严重的不良反应。一名51岁男性在开始服用MMI治疗格雷夫斯病两周后出现高热、寒战和腹痛。没有粒细胞缺乏症的证据,停用MMI治疗后发热很快消退。然而,在再次服用一剂MMI 5小时后,腹痛和发热再次出现。他的症状、生化检查和影像学研究均符合急性胰腺炎。停用MMI后,他的临床症状有所改善。这是韩国首例MMI诱发的急性胰腺炎病例。临床医生应意识到,在主诉发热和腹痛的患者中,MMI诱发胰腺炎虽罕见但有可能发生。